# Safety, Tolerability and Pharmacokinetic Study of ASP1517 in Healthy Non-elderly Male Volunteers

> **NCT00978198** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 100 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ASP1517
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00978198
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2010-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00978198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00978198, "Safety, Tolerability and Pharmacokinetic Study of ASP1517 in Healthy Non-elderly Male Volunteers". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00978198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*